Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.61
Delayed Data
As of Apr 21
 +0.02 / +0.36%
Today’s Change
5.25
Today|||52-Week Range
6.45
-4.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues23.0M11.0M1.4M28.7M
 
 
 
 
 
Cost of Goods Sold6.0M3.2M2.3M4.5M
 
 
 
 
 
Depreciation And Amortization1.3M1.4M1.4M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income15.7M6.3M-2.4M23.0M
 
 
 
 
 
General Expenses14.0M8.5M11.4M17.0M
 
 
 
 
 
Other Operating Expenses0.00--0.00-329.0K
 
 
Research And Development2.9M2.1M2.8M4.2M
 
 
 
 
 
Total Operating Expenses21.3M13.1M15.1M22.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.7M-2.2M-13.7M6.4M
 
 
 
 
 
Interest Expense On Debt418.0K383.0K401.0K352.0K
 
 
 
 
 
Other Expenses991.0K646.0K-47.0K-330.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.5M-1.6M-14.0M5.8M
 
 
 
 
 
Income Taxes-1.3M-52.0K-1.4M-1.5M
 
 
 
 
 
Minority Interest-651.0K-560.0K-3.0M-1.1M
 
 
 
 
 
Discontinued Operations-109.0K2.3M0.000.00
 
 
 
Net Income504.0K1.3M-9.6M3.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.9M56.9M56.9M57.0M
 
 
 
 
 
Shares To Calculate EPS Diluted57.0M57.0M56.9M57.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.01$0.02-$0.17$0.06
 
 
 
 
 
EPS Diluted$0.01$0.02-$0.17$0.06